ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Outcomes of Second Kidney Transplant After Return to Dialysis by Induction Type in the United States

S. Riad1, T. Shaker1, S. Jackson2, R. Kandaswamy3

1Medicine, University of Minnesota, Minneapolis, MN, 2Complex Care Analytics, M-Health Fairview, Minneapolis, MN, 3Surgery, University of Minnesota, Minneapolis, MN

Meeting: 2021 American Transplant Congress

Abstract number: 925

Keywords: Induction therapy, Outcome, Retransplantation

Topic: Clinical Science » Kidney » Kidney Immunosuppression: Induction Therapy

Session Information

Session Name: Kidney Immunosuppression: Induction Therapy

Session Type: Poster Abstract

Session Date & Time: None. Available on demand.

Location: Virtual

*Purpose: A failed kidney allograft is the 4th leading indication for kidney transplantation. We examined the association of induction use in 2nd kidney transplant recipients after returning to dialysis and the long-term recipient survival (RS) and death censored graft survival (DCGS).

*Methods: Using the SRTR database, we identified all 2nd kidney recipients who returned to dialysis before re-transplantation. We excluded those with missing or unusual induction regimens, recipients with maintenance other than Tac and MMF +/- steroids and those with crossmatch positive results. We grouped recipients by induction type into 4 groups: Anti-thymocyte globulin (n=9233), Alemtuzumab (n=1846), IL-2RA (n=1969) and No-induction (n=811). We generated Kaplan-Meier curves of (RS) and (DCGS) with follow up censored at 10-year post-transplant. We used Cox proportional hazard (PH) models to examine the association of induction with these outcomes. We included center as a random effect. We adjusted for recipient age, gender, race, DM, PVD, ESRD etiology, donor type and gender, HLA-MM, steroid maintenance, time between transplants, payor type and transplant year. The (RS) model was stratified by transplant year; the (DCGS) model was stratified by time between transplants, time on dialysis, recipient age and donor age due to (PH) violations.

*Results: Rejection and PTLD rates at 1-year were not statistically different. DGF and re-hospitalization rates were lower, but mean creatinine was higher in the no induction group compared to the other groups. In the univariate analyses, (RS) did not differ by induction type (log-rank p=0.50). However, (DCGS) was the lowest in the no-induction group (log-rank p <0.001) (Figure 1). After adjustment, induction type was not a predictor of (RS) or (DCGS). Steroid maintenance was associated with better (DCGS) [aHR 0.86, 95% C.I. (0.76, 0.98), p=0.02]. Live-donor kidney was a favorable predictor of (RS) [aHR 0.75, 95% C.I. (0.67, 0.85), p<0.001] and (DCGS) [aHR 0.75, 95% C.I. (0.67, 0.85), p<0.001]. Publicly insured recipients had worse (RS) and (DCGS).

*Conclusions: In this large cohort of crossmatch negative second kidney transplant recipients, who were on dialysis prior to re-transplantation and discharged on Tac and MMF maintenance, recipients of no-induction had worse graft survival in the univariate analysis. In the fully adjusted models, induction type was not a predictor of (RS) or (DCGS). Live-donor kidneys improved recipient and graft survival.

 border=

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

To cite this abstract in AMA style:

Riad S, Shaker T, Jackson S, Kandaswamy R. Outcomes of Second Kidney Transplant After Return to Dialysis by Induction Type in the United States [abstract]. Am J Transplant. 2021; 21 (suppl 3). https://atcmeetingabstracts.com/abstract/outcomes-of-second-kidney-transplant-after-return-to-dialysis-by-induction-type-in-the-united-states/. Accessed June 1, 2025.

« Back to 2021 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences